Jie Cheng Zhang
Director/Board Member at Hillhouse Capital Group Ltd.
Profile
Jie Cheng Zhang is currently an Executive Director at Hillhouse Capital Group Ltd., a Non-Executive Director at Innovex Medical Co., Ltd., an Executive Director at HeMo (China) Bioengineering Co., Ltd., a Director at HeMo (China) Bioengineering Ltd., and an Executive Director at Zhuhai Gao Ling Equity Investment Management Co. Ltd.
Previously, Mr. Zhang was a Non-Executive Director at Suzhou Basecare Medical Corp.
Ltd.
from 2020 to 2023.
Mr. Zhang received an undergraduate degree from Shanghai University of Finance & Economics in 2012.
Jie Cheng Zhang active positions
| Companies | Position | Start |
|---|---|---|
Hillhouse Capital Group Ltd.
 Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Director/Board Member | 2016-05-31 |
HeMo (China) Bioengineering Co., Ltd.
 HeMo (China) Bioengineering Co., Ltd. Information Technology ServicesTechnology Services HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China. | Director/Board Member | 2020-10-15 |
| HeMo (China) Bioengineering Ltd. | Director/Board Member | 2020-10-31 |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Director/Board Member | 2015-05-31 |
Innovex Medical Co., Ltd.
 Innovex Medical Co., Ltd. Medical SpecialtiesHealth Technology Innovex Medical Co., Ltd. provides surgical solutions. It is a provider of integrated non-vascular interventional surgical solutions in China with a global vision. It offer integrated solutions of endoscopes, active medical devices and non-active consumables for all major medical specialties that perform non-vascular interventional surgery, including urology, gastroenterology, hepatobiliary, respiratory, thoracic surgery, otorhinolaryngology, gynecology and general surgery. The company was founded in February 02, 2009 and is headquartered in Shanghai, China. | Director/Board Member | 2021-10-18 |
Former positions of Jie Cheng Zhang
| Companies | Position | End |
|---|---|---|
| SUZHOU BASECARE MEDICAL CORPORATION LIMITED | Director/Board Member | 2023-01-10 |
Training of Jie Cheng Zhang
| Shanghai University of Finance & Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SUZHOU BASECARE MEDICAL CORPORATION LIMITED | Health Technology |
| Private companies | 5 |
|---|---|
Hillhouse Capital Group Ltd.
Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Finance |
HeMo (China) Bioengineering Co., Ltd.
HeMo (China) Bioengineering Co., Ltd. Information Technology ServicesTechnology Services HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China. | Technology Services |
| HeMo (China) Bioengineering Ltd. | |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. | |
Innovex Medical Co., Ltd.
Innovex Medical Co., Ltd. Medical SpecialtiesHealth Technology Innovex Medical Co., Ltd. provides surgical solutions. It is a provider of integrated non-vascular interventional surgical solutions in China with a global vision. It offer integrated solutions of endoscopes, active medical devices and non-active consumables for all major medical specialties that perform non-vascular interventional surgery, including urology, gastroenterology, hepatobiliary, respiratory, thoracic surgery, otorhinolaryngology, gynecology and general surgery. The company was founded in February 02, 2009 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Jie Cheng Zhang
